Anthracyclines for HER2-Positive Early Breast Cancer

feeds has 409 videos Subscribe Here

Description: The continued use of anthracyclines in the adjuvant treatment of patients with early-stage HER2-positive breast cancer is an area that has posed many questions in recent years. Moderator, Debu Tripathy, MD, explains that some physicians are considering abandoning the use of anthracyclines, due to recent clinical trials and the toxicity profile.

For more from this discussion, visit
Shared By : feeds
Posted on : 11/06/12
Added : 7 years ago
Category : Breast Cancer